The initial basis of the drug will be the smallpox vaccine. According to preliminary information, the spike protein of the SARS-CoV-2 virus will be included in the recombinant vaccinia virus.
A vaccine like this could give patients lifelong immunity. It has already been announced that a single dose of this vaccine retains its antiviral effect for more than 20 months.
Japan is currently using vaccines from Pfizer, BioNTech, Moderna and AstraZeneca in a public vaccination campaign.
– .
Related posts:
"U.S. Launches Retaliatory Strike on Houthi Targets in Yemen Amid Continued Attacks on International...
Miami Heat - Charlotte Hornets: Result, summary and live statistics of the NBA game
United States: a pastor in campaign in Georgia
Red Arrow-12: China's Equivalent to the US Javelin Anti-Tank Missile System
